Advertisement

February 21, 2020

Fist Assist Device Approved and Launched in Europe

February 21, 2020—Fist Assist Devices, LLC, announced CE Mark approval for its wearable Fist Assist intermittent compression device to increase vein diameter before fistula placement and to assist in fistula vein dilation for hemodialysis for end-stage renal disease patients. The company has begun marketing the Fist Assist device for vein enhancement and enlargement in the European Union and other countries that recognize the CE Mark, including India. The device is not available in the United States.

In the company’s announcement, surgeon Nick Inston, MD, commented, “Fist Assist provides a patient-focused evidence-based approach to surgical vein enhancement for all types of arteriovenous fistulas and can be used to enhance veins before fistula creation as well as after surgery to improve maturation. Access surgery and subsequent maturation is a major challenge and adjuncts to improve outcomes are desperately needed. Fist Assist is a creative solution which for the first time allows patients to be involved and directly influence their clinical outcomes with a comfortable and easy to use device.” Dr. Inston is Specialist Vascular Access Surgeon at University Hospitals Birmingham, in Birmingham, United Kingdom, which is one of the largest renal/dialysis centers in Europe, noted the company.

Advertisement


February 24, 2020

Study Highlights Limitations of Resting ABI in the Diagnosis of Symptomatic PAD

February 21, 2020

No Mortality Difference Observed in JEVT Meta-Analysis of CLTI Patients Treated With Paclitaxel